Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Therapeutic Delivery|September 6, 2012
Targeting malignant mitochondria with therapeutic peptidesJonathan E Constance, Carol S Lim
Pharmaceutical Research|May 3, 2012
Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cellsJonathan E Constance, Samuel D Despres, Akemi Nishida, et al.
Molecular Pharmaceutics|March 3, 2012
Direct induction of apoptosis using an optimal mitochondrially targeted p53Mohanad Mossalam, Karina J Matissek, Abood Okal, et al.
Pharmaceutical Research|December 21, 2011
Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifsAndrew S Dixon, Jonathan E Constance, Tomoyuki Tanaka, et al.
Molecular Pharmaceutics|September 11, 2012
Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinibJonathan E Constance, David W Woessner, Karina J Matissek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
Molecular Pharmaceutics|December 6, 2011
Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosisAndrew S Dixon, Geoffrey D Miller, Benjamin J Bruno, et al.
JMIR Research Protocols|May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping ReviewJonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Pageof 8